News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
12-Sep-2001 - Microorganisms such as yeasts, moulds, bacteria and viruses constitute a large risk to human health throughout the world. Less well known is the fact that microbes cause material damage and corrosion, thereby destroying billions of dollars worth of assets every year. Biocides can prevent this, ...
First approved PCR-based test to detect Hepatitis C Virus
10-Jul-2001 - The U.S. Food and Drug Administration (FDA) has granted marketing approval for Roche’s two hepatitis C tests designed to directly detect the presence of the Hepatitis C virus (HCV) in the blood. Roche’s Amplicor HCV Test (version 2.0) and Cobas Amplicor HCV Test (version 2.0) are the first ...
05-Jul-2001 - The biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the start of a phase 1/2 clinical trial for a vaccine against malignant melanoma developed together with Aventis Pharma AG. The therapeutic vaccination is based on gene transfer by so-called adeno-associated viruses (AAV). ...
28-May-2001 - GPC Biotech (Frankfurt Stock Exchange: GPC), a leading genomics- and proteomics-driven drug discovery company, today announced a successful course of the business for the first quarter 2001. The Company reported that revenues increased from EUR 1.0 million to EUR 2.8 million, an increase of ...
30-Apr-2001 - The biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the issuance of US-Patent US 6,207,453. The granted patent protects a method which allows a safe and efficient integration of foreign DNA into target cells using recombinant Adeno Associated Viruses (rAAV). MediGene’s ...
25-Apr-2001 - he biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the issuance of US-Patent US 6,207,453. The granted patent protects a method which allows a safe and efficient integration of foreign DNA into target cells using recombinant Adeno Associated Viruses (rAAV). MediGene’s ...
01-Feb-2001 - The biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the issuance of US-Patent US 6,171,595. The granted patent protects MediGene’s method for using recombinant adeno-associated viruses (AAV) to produce tumor vaccines. On the basis of the so-called AAV-technology MediGene is ...
16-Jan-2001 - The German biopharmaceutical company MediGene AG (NMarkt: MDG) announced today the closing of the acquisition of NeuroVir Therapeutics, Inc. (San Diego, CA), a biopharmaceutical company developing modified herpes simplex viruses (HSV) for use in cancer therapy. Currently NeuroVir has two product ...
05-Jan-2001 - The German biopharmaceutical company MediGene AG, Munich, (NMarkt: MDG), announced today that a phase 3 trial for Polyphenon™E to treat genital warts caused by Human Papilloma Viruses was initiated end of December 2000. MediGene currently has three product candidates in clinical trials ...
© 1997-2024 LUMITOS AG, All rights reserved